Opportunity Information: Apply for RFA CA 22 015
The National Institutes of Health (NIH) funding opportunity titled "Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)" (RFA-CA-22-015; CFDA 93.393) is a discretionary cooperative agreement designed to strengthen cancer prevention and control research capacity in U.S. communities experiencing persistent poverty. The central idea is to invest in sustained, place-based research programs that are built and carried out by transdisciplinary teams working hand-in-hand with local communities and clinical partners. Rather than supporting a single isolated project, the U54 structure is meant to help applicants develop a coordinated research program that can grow over time, address real-world barriers to cancer prevention and care, and produce findings that are practical for implementation in the settings where poverty-related disparities are most entrenched. The "clinical trial optional" designation means applicants may propose studies that include clinical trials if appropriate, but clinical trials are not required.
The purpose of the FOA is twofold. First, it provides resources to cover the time and effort needed for cross-sector teams to collaboratively build a cancer prevention and control research program that specifically focuses on populations living in persistent poverty areas. This emphasizes collaboration with both communities and clinics, signaling that NIH expects meaningful partnership with people and institutions on the ground, not just academic-led research conducted at a distance. Second, it explicitly prioritizes training and career development for junior investigators, with the goal of creating a pipeline of researchers who are equipped to do high-quality, community-engaged cancer control work in underserved, low-resource contexts. In practice, this implies that competitive proposals will likely show not only what research will be done, but also how new investigators will be mentored, supported, and positioned to continue this work long after the award period ends.
The long-term goal is capacity building: strengthening the ability of persistent poverty areas to generate, test, and implement cancer prevention and control strategies that reduce inequities. The FOA is grounded in the recognition that persistent poverty is associated with structural barriers that can worsen cancer outcomes, such as limited access to screening and timely treatment, fewer preventive services, transportation challenges, under-resourced clinics, and broader social determinants that influence risk and survivorship. NIH is therefore aiming to foster research that leads to implementable programs and practices in communities, with an emphasis on reducing the cancer burden while also helping alleviate the effects of persistent poverty through better-designed interventions, partnerships, and service delivery approaches.
As a cooperative agreement, the U54 mechanism typically involves substantial scientific or programmatic involvement from NIH staff compared with a standard grant. While applicants still lead the work, the cooperative agreement format generally signals an expectation of ongoing coordination, shared problem-solving, and alignment with program goals. This often fits initiatives that are trying to build networks, create shared infrastructure, or accelerate implementation of evidence-based approaches across multiple local partners.
Eligibility is broad and includes many domestic entity types: state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with or without 501(c)(3) status (outside higher education); for-profit organizations other than small businesses; small businesses; and other organizations. The FOA also calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, Indian/Native American Tribal Governments other than federally recognized, and U.S. territories or possessions. At the same time, the opportunity is strictly domestic in its funding reach: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply; non-domestic components of U.S. organizations are not eligible; and foreign components as defined by NIH policy are not allowed.
The opportunity was created on March 8, 2022, and the original closing date listed is July 6, 2022. Award ceiling and expected number of awards are not specified in the provided source data, which typically means applicants would need to consult the full FOA text for budget limits, project period length, and any caps on direct costs. Overall, this FOA is best understood as an NIH effort to seed durable, community-centered cancer control research and training ecosystems in places where persistent poverty contributes to preventable cancer disparities, with a strong emphasis on partnerships, implementation relevance, and developing the next generation of investigators committed to this work.Apply for RFA CA 22 015
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393.
- This funding opportunity was created on 2022-03-08.
- Applicants must submit their applications by 2022-07-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title of this NIH funding opportunity?
The funding opportunity is titled "Cancer Control Research in Persistent Poverty Areas (U54 Clinical Trial Optional)."
What is the FOA number and CFDA listing provided?
The FOA number provided is RFA-CA-22-015, and the CFDA number listed is 93.393.
What type of funding mechanism is this?
This opportunity uses a U54 cooperative agreement mechanism, described as a discretionary cooperative agreement.
What does it mean that this is a cooperative agreement?
As described, the cooperative agreement format typically involves substantial scientific or programmatic involvement from NIH staff compared with a standard grant. Applicants still lead the work, but NIH expects ongoing coordination, shared problem-solving, and alignment with program goals.
What does "clinical trial optional" mean for applicants?
"Clinical trial optional" means applicants may propose studies that include clinical trials if appropriate, but clinical trials are not required.
What is the central idea behind this opportunity?
The central idea is to invest in sustained, place-based cancer prevention and control research programs in U.S. communities experiencing persistent poverty, carried out by transdisciplinary teams working closely with local communities and clinical partners.
Is this grant intended to fund a single research project?
No. The description emphasizes that the U54 structure is meant to support a coordinated research program that can grow over time rather than a single isolated project.
What are the main goals (purpose) of the FOA?
The FOA purpose is described as twofold: (1) provide resources for cross-sector teams to collaboratively build a cancer prevention and control research program focused on populations living in persistent poverty areas, and (2) prioritize training and career development for junior investigators to build a pipeline of researchers skilled in community-engaged cancer control work.
What kinds of partnerships does NIH appear to expect?
The opportunity emphasizes meaningful collaboration with communities and clinics, indicating NIH expects partnerships with people and institutions on the ground rather than research conducted at a distance.
What is meant by "place-based" research in this context?
Based on the description, "place-based" refers to sustained research programs rooted in specific U.S. communities experiencing persistent poverty, designed to address real-world barriers to cancer prevention and care in those settings.
What kinds of research topics or focus areas fit this FOA?
The FOA focuses on cancer prevention and control research that addresses poverty-related disparities and structural barriers associated with persistent poverty, such as limited access to screening and timely treatment, fewer preventive services, transportation challenges, under-resourced clinics, and broader social determinants that influence risk and survivorship.
What is the long-term goal of the program?
The long-term goal is capacity building: strengthening the ability of persistent poverty areas to generate, test, and implement cancer prevention and control strategies that reduce inequities.
What does "capacity building" mean in this opportunity?
In the description provided, capacity building refers to strengthening local and regional ability to conduct cancer prevention and control research and to implement practical, evidence-informed strategies in communities and clinical settings where poverty-related disparities are entrenched.
How important is implementation and real-world practicality?
The description emphasizes producing findings that are practical for implementation and fostering research that leads to implementable programs and practices in community and clinic settings.
What does NIH say about training and career development?
The FOA explicitly prioritizes training and career development for junior investigators, implying proposals should describe how new investigators will be mentored, supported, and positioned to continue this work beyond the award period.
Who is eligible to apply?
Eligibility is broad and includes many domestic entity types, including (as listed): state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with or without 501(c)(3) status (outside higher education); for-profit organizations other than small businesses; small businesses; and other organizations.
Are community-based and faith-based organizations eligible?
Yes. The information provided explicitly calls out faith-based or community-based organizations among eligible applicants.
Are minority-serving institutions (MSIs) specifically mentioned as eligible?
Yes. The FOA information calls out eligibility for Alaska Native and Native Hawaiian Serving Institutions, AANAPISISs, Hispanic-serving Institutions, HBCUs, TCCUs, and other specified organizations.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are explicitly included in the eligibility callouts.
Are eligible federal agencies included?
Yes. The information provided includes eligible federal agencies among additional eligible applicants.
Can foreign (non-U.S.) organizations apply?
No. Non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply.
Can a U.S. organization include a non-domestic component?
No. Non-domestic components of U.S. organizations are not eligible, and foreign components as defined by NIH policy are not allowed.
Is this opportunity limited to the United States?
Yes. The funding reach is described as strictly domestic, with foreign organizations and foreign components disallowed.
When was this opportunity created?
The opportunity was created on March 8, 2022.
What is the closing date listed in the provided information?
The original closing date listed is July 6, 2022.
Are the award ceiling and expected number of awards provided?
No. The award ceiling and expected number of awards are not specified in the provided source data.
Is information on budget limits, project period length, or direct cost caps included here?
No. The provided information indicates applicants would typically need to consult the full FOA text for budget limits, project period length, and any caps on direct costs.
What distinguishes this FOA from a standard academic-led research approach?
The description emphasizes sustained, coordinated programs built by transdisciplinary teams working hand-in-hand with local communities and clinical partners, with a focus on practical implementation in low-resource, persistent poverty settings.
What kinds of barriers is this FOA trying to address?
The FOA is grounded in recognition of structural barriers associated with persistent poverty that can worsen cancer outcomes, including limited access to screening and timely treatment, fewer preventive services, transportation challenges, under-resourced clinics, and other social determinants affecting risk and survivorship.
What is the overall intent of NIH with this FOA?
Overall, the FOA is described as an NIH effort to seed durable, community-centered cancer control research and training ecosystems in places where persistent poverty contributes to preventable cancer disparities, emphasizing partnerships, implementation relevance, and development of the next generation of investigators.
Browse more opportunities from the same category: Education, Health
Next opportunity: Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
Previous opportunity: Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 22 015
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 22 015) also looked into and applied for these:
| Funding Opportunity |
|---|
| Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) Apply for PAR 22 123 Funding Number: PAR 22 123 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed) Apply for RFA HL 23 007 Funding Number: RFA HL 23 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R21 - Clinical Trial Not Allowed) Apply for RFA DA 23 009 Funding Number: RFA DA 23 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Enhancing Social Connectedness and Ameliorating Loneliness to Prevent and Treat SUD and Support Recovery (R34 - Clinical Trial Optional) Apply for RFA DA 23 010 Funding Number: RFA DA 23 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Short-Term Research Education Experiences to Attract Talented Students to Biomedical Informatics/Data Science Careers and Enhance Diversity (R25 Clinical Trial Not Allowed) Apply for RFA LM 22 001 Funding Number: RFA LM 22 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: $125,000 |
| NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) Apply for PAR 22 133 Funding Number: PAR 22 133 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, Cocaine and/or Cannabinoid Exposures (U01 - Clinical Trial Not Allowed) Apply for RFA DA 23 004 Funding Number: RFA DA 23 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) Apply for RFA DA 23 014 Funding Number: RFA DA 23 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 22 017 Funding Number: RFA CA 22 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed) Apply for PAR 22 126 Funding Number: PAR 22 126 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Focused Technology Research and Development (R01 Clinical Trial Not Allowed) Apply for PAR 22 127 Funding Number: PAR 22 127 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 22 023 Funding Number: RFA CA 22 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 22 024 Funding Number: RFA CA 22 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Apply for RFA CA 22 022 Funding Number: RFA CA 22 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) Apply for RFA CA 22 021 Funding Number: RFA CA 22 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 013 Funding Number: RFA CA 22 013 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Patient Derived Xenograft (PDX) Development and Trial Centers (PDTCs) Network (U54 Clinical Trial Not Allowed) Apply for RFA CA 22 012 Funding Number: RFA CA 22 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional) Apply for RFA DA 23 021 Funding Number: RFA DA 23 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed) Apply for RFA AI 22 025 Funding Number: RFA AI 22 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional) Apply for PAR 22 145 Funding Number: PAR 22 145 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 22 015", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.